FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2145220982> ?p ?o ?g. }

• W2145220982 endingPage "3224" @default.
• W2145220982 startingPage "3211" @default.
• W2145220982 abstract "// Katsuya Ohta 1 , Hiromitsu Hoshino 1 , Jinhua Wang 1 , Shigeshi Ono 1 , Yuuki Iida 1 , Keisuke Hata 1 , Sharon K. Huang 1 , Steven Colquhoun 2 and Dave S. B. Hoon 1 1 Department of Molecular Oncology, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA, USA 2 Liver Disease and Transplant Center, Cedars-Sinai Medical Center, Beverly Hills, CA, USA Correspondence: Dave S. B. Hoon, email: // Keywords : miR-93, hepatocellular carcinoma, drug-sensitivity, sorafenib and tivantinib Received : September 09, 2014 Accepted : December 23, 2014 Published : December 26, 2014 Abstract To assess the role of microRNAs (miR) in hepatocellular carcinoma (HCC), we performed comprehensive microRNA expression profiling using HCC cell lines and identified miR-93 as a novel target associated with HCC. We further verified miR-93 expression levels in advanced HCC tumors (n=47) by a direct PCR assay and found that elevated miR-93 expression level is significantly correlated with poor prognosis. Elevated miR-93 expression significantly stimulated in vitro cell proliferation, migration and invasion, and additionally inhibited apoptosis. We confirmed that miR-93 directly bound with the 3’ untranslated regions of the tumor-suppressor genes PTEN and CDKN1A , respectively,and inhibited their expression. As a result of this inhibition, the c-Met/PI3K/Akt pathway activity was enhanced. IHC analysis of HCC tumors showed significant correlation between c-Met protein expression levels and miR-93 expression levels. Knockdown of c-Met inhibited the activation of the c-Met/PI3K/Akt pathway regardless of hepatocyte growth factor (HGF) treatment, and furthermore reduced the expression of miR-93 in these HCC cells. miR-93 also rendered cells to be more sensitive to sorafenib and tivantinib treatment. We concluded that miR-93 stimulated cell proliferation, migration, and invasion through the oncogenic c-Met/PI3K/Akt pathway and also inhibited apoptosis by directly inhibiting PTEN and CDKN1A expression in human HCC." @default.
• W2145220982 created "2016-06-24" @default.
• W2145220982 creator A5014353611 @default.
• W2145220982 creator A5034641530 @default.
• W2145220982 creator A5044921362 @default.
• W2145220982 creator A5068569188 @default.
• W2145220982 creator A5070627622 @default.
• W2145220982 creator A5071544706 @default.
• W2145220982 creator A5073659871 @default.
• W2145220982 creator A5082489689 @default.
• W2145220982 creator A5083524449 @default.
• W2145220982 date "2014-12-26" @default.
• W2145220982 modified "2023-10-13" @default.
• W2145220982 title "MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A" @default.
• W2145220982 cites W144423133 @default.
• W2145220982 cites W1971837077 @default.
• W2145220982 cites W1976628534 @default.
• W2145220982 cites W1982154889 @default.
• W2145220982 cites W1990645475 @default.
• W2145220982 cites W1992976746 @default.
• W2145220982 cites W1994193851 @default.
• W2145220982 cites W2004339436 @default.
• W2145220982 cites W2009886463 @default.
• W2145220982 cites W2015977354 @default.
• W2145220982 cites W2019768326 @default.
• W2145220982 cites W2021181675 @default.
• W2145220982 cites W2021827559 @default.
• W2145220982 cites W2022013872 @default.
• W2145220982 cites W2030209959 @default.
• W2145220982 cites W2039340234 @default.
• W2145220982 cites W2046299975 @default.
• W2145220982 cites W2051684210 @default.
• W2145220982 cites W2059794606 @default.
• W2145220982 cites W2067691895 @default.
• W2145220982 cites W2094337993 @default.
• W2145220982 cites W2101619787 @default.
• W2145220982 cites W2111125738 @default.
• W2145220982 cites W2125229905 @default.
• W2145220982 cites W2130982817 @default.
• W2145220982 cites W2137111781 @default.
• W2145220982 cites W2137794530 @default.
• W2145220982 cites W2139438188 @default.
• W2145220982 cites W2140587309 @default.
• W2145220982 cites W2149385948 @default.
• W2145220982 cites W2152091242 @default.
• W2145220982 cites W2161810908 @default.
• W2145220982 cites W2161844910 @default.
• W2145220982 cites W2168420558 @default.
• W2145220982 cites W2388163742 @default.
• W2145220982 cites W2396552177 @default.
• W2145220982 cites W4245881395 @default.
• W2145220982 doi "https://doi.org/10.18632/oncotarget.3085" @default.
• W2145220982 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4413648" @default.
• W2145220982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25633810" @default.
• W2145220982 hasPublicationYear "2014" @default.
• W2145220982 type Work @default.
• W2145220982 sameAs 2145220982 @default.
• W2145220982 citedByCount "135" @default.
• W2145220982 countsByYear W21452209822015 @default.
• W2145220982 countsByYear W21452209822016 @default.
• W2145220982 countsByYear W21452209822017 @default.
• W2145220982 countsByYear W21452209822018 @default.
• W2145220982 countsByYear W21452209822019 @default.
• W2145220982 countsByYear W21452209822020 @default.
• W2145220982 countsByYear W21452209822021 @default.
• W2145220982 countsByYear W21452209822022 @default.
• W2145220982 countsByYear W21452209822023 @default.
• W2145220982 crossrefType "journal-article" @default.
• W2145220982 hasAuthorship W2145220982A5014353611 @default.
• W2145220982 hasAuthorship W2145220982A5034641530 @default.
• W2145220982 hasAuthorship W2145220982A5044921362 @default.
• W2145220982 hasAuthorship W2145220982A5068569188 @default.
• W2145220982 hasAuthorship W2145220982A5070627622 @default.
• W2145220982 hasAuthorship W2145220982A5071544706 @default.
• W2145220982 hasAuthorship W2145220982A5073659871 @default.
• W2145220982 hasAuthorship W2145220982A5082489689 @default.
• W2145220982 hasAuthorship W2145220982A5083524449 @default.
• W2145220982 hasBestOaLocation W21452209821 @default.
• W2145220982 hasConcept C104317684 @default.
• W2145220982 hasConcept C143998085 @default.
• W2145220982 hasConcept C145059251 @default.
• W2145220982 hasConcept C173396325 @default.
• W2145220982 hasConcept C190283241 @default.
• W2145220982 hasConcept C2776231280 @default.
• W2145220982 hasConcept C2777609662 @default.
• W2145220982 hasConcept C2778019345 @default.
• W2145220982 hasConcept C2778695046 @default.
• W2145220982 hasConcept C502942594 @default.
• W2145220982 hasConcept C54355233 @default.
• W2145220982 hasConcept C55493867 @default.
• W2145220982 hasConcept C62112901 @default.
• W2145220982 hasConcept C71924100 @default.
• W2145220982 hasConcept C75217442 @default.
• W2145220982 hasConcept C86554907 @default.
• W2145220982 hasConcept C86803240 @default.
• W2145220982 hasConceptScore W2145220982C104317684 @default.
• W2145220982 hasConceptScore W2145220982C143998085 @default.
• W2145220982 hasConceptScore W2145220982C145059251 @default.

• next